Compare ACNT & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACNT | PRE |
|---|---|---|
| Founded | 1945 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.8M | 131.3M |
| IPO Year | N/A | N/A |
| Metric | ACNT | PRE |
|---|---|---|
| Price | $14.80 | $14.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 112.4K | ★ 134.1K |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $171,413,000.00 | $77,079,000.00 |
| Revenue This Year | $22.72 | $202.46 |
| Revenue Next Year | N/A | $103.60 |
| P/E Ratio | $161.19 | ★ N/A |
| Revenue Growth | 65.05 | ★ 201.54 |
| 52 Week Low | $10.76 | $3.10 |
| 52 Week High | $15.60 | $17.99 |
| Indicator | ACNT | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 67.47 | 53.03 |
| Support Level | $14.09 | $11.37 |
| Resistance Level | $15.60 | $14.97 |
| Average True Range (ATR) | 0.56 | 1.18 |
| MACD | 0.09 | 0.20 |
| Stochastic Oscillator | 67.77 | 70.16 |
Ascent Industries Co is a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions. It has one reportable segment: Specialty Chemicals. The Specialty Chemicals segment includes the operating results of the Company's plants involved in the production of specialty chemicals and produces critical ingredients and process aids for the oil & gas, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), pulp and paper, textile, automotive, agricultural, water treatment, construction and other industries.
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.